Berchem, Belgium

Inge Dierynck

This inventor holds 3 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Janssen R&d Ireland, Tibotec Pharmaceuticals Ltd.. Active years: 2012-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Inge Dierynck. Retrieved from https://idiyas.com/inventor/inge-dierynck-3qrfk3ic

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 33.3


 

Average Co-Inventor Count = 3.4

ph-index = 1


Company Filing History:


Years Active: 2012-2013

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Inventor Inge Dierynck - Revolutionizing Technology in Berchem, BE

Introduction: Inge Dierynck is a pioneering inventor based in Berchem, Belgium, known for her groundbreaking contributions to the field of technology.

Latest Patents: Inge Dierynck holds several patents in the realm of artificial intelligence and sustainable energy solutions, showcasing her innovative mindset and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Inge Dierynck has been at the forefront of technological advancements, leading teams to develop cutting-edge solutions that have reshaped industries.

Collaborations: Throughout her career, Inge Dierynck has collaborated with top research institutions and leading tech companies to bring her inventions to life, fostering a culture of innovation and excellence.

Conclusion: Inge Dierynck's passion for innovation and her relentless drive to push the boundaries of technology make her a true trailblazer in the world of inventions. Her work continues to inspire future generations of inventors worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…